French National Institute of Health and Medical Research-医療機器分野:企業M&A・提携分析

◆英語タイトル:French National Institute of Health and Medical Research - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011679
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immunology, inflammation, genetics, cancer, infectiology and microbiology, physiopathology, public health, health technologies, metabolism, cell biology and immunology, among others. It provides services in the areas of human diseases and research findings to the medical community, and to both national and international partners. INSERM also conducts translational research and development services. It operates research units and research centers. INSERM is headquartered in Paris, France.

French National Institute of Health and Medical Research – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2011 to YTD 2017 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
French National Institute of Health and Medical Research, Medical Equipment, Deal Details 11
Partnerships 11
Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 11
Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 12
Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 13
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 14
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 16
Dassault Systemes Enters into Agreement with Inserm Transfert 17
Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 18
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 19
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 20
Inserm Transfert Enters into Licensing Agreement with HalioDx 21
French National Institute of Health and Medical Research – Key Competitors 22
French National Institute of Health and Medical Research – Key Employees 23
French National Institute of Health and Medical Research – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Affiliate 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
French National Institute of Health and Medical Research, Medical Equipment, Key Facts 2
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2011 to YTD 2017 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Deals By Market, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 11
Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 12
Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 13
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 14
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 16
Dassault Systemes Enters into Agreement with Inserm Transfert 17
Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 18
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 19
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 20
Inserm Transfert Enters into Licensing Agreement with HalioDx 21
French National Institute of Health and Medical Research, Key Competitors 22
French National Institute of Health and Medical Research, Key Employees 23
French National Institute of Health and Medical Research, Subsidiaries 24
French National Institute of Health and Medical Research, Affiliate 24

★海外企業調査レポート[French National Institute of Health and Medical Research-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Netherlands Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • IOL Chemicals and Pharmaceuticals Ltd (IOLCP):企業の財務・戦略的SWOT分析
    IOL Chemicals and Pharmaceuticals Ltd (IOLCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Painted Pony Energy Ltd (PONY):石油・ガス:M&Aディール及び事業提携情報
    Summary Painted Pony Energy Ltd (Painted Pony Energy), formerly Painted Pony Petroleum Ltd is a natural gas producer that offers production development drilling for natural gas and natural gas liquids. The company offers development of its premium, sweet natural gas resource base located in the opti …
  • Genae Associates NV:医療機器:M&Aディール及び事業提携情報
    Summary Genae Associates NV (Genae Group) is a medical device CRO that offers clinical trial management services. The organization develops and commercializes investigational products and therapies that advance practices in medicine. Its services comprise clinical trial management, regulatory and sa …
  • Datatec Ltd (DTC):企業の財務・戦略的SWOT分析
    Datatec Ltd (DTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MSL Solutions Limited (MPW):企業の財務・戦略的SWOT分析
    MSL Solutions Limited (MPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • One Call Care Management Inc-医療機器分野:企業M&A・提携分析
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc is a healthcare technology provider that offers specialized cost containment services. The company provides diagnostics, dental, transport, complex home care, equipment and physical therapy. It offers value added service and …
  • Infinity Pharmaceuticals Inc (INFI):製薬・医療:M&Aディール及び事業提携情報
    Summary Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of cancer. The company’s pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and …
  • Flex Foods Ltd:企業の戦略・SWOT・財務情報
    Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Pharmaron Beijing Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaron Beijing Co Ltd (Pharmaron) is a life science service company that provides drug research and development services in the areas of chemistry, biology, pharmacology, DMPK, toxicology, and chemical development. The company's service offerings include synthetic, medicinal and analytica …
  • Sociedad Minera El Brocal SAA (BROCALC1):企業の財務・戦略的SWOT分析
    Sociedad Minera El Brocal SAA (BROCALC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Pfizer Inc (PFE)-医療機器分野:企業M&A・提携分析
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • Akonni Biosystems Inc-医療機器分野:企業M&A・提携分析
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company’s products include nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray readers and …
  • J. C. Penney Company, Inc.:企業の戦略・SWOT・財務情報
    J. C. Penney Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary J. C. Penney Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Twist Bioscience Corp (TWST):医療機器:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • AbbVie Inc (ABBV)-製薬・医療分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …
  • Emzor Pharmaceutical Industries Ltd:企業の戦略的SWOT分析
    Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Tanner Pharma Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tanner Pharma Group Inc (Tanner Pharma), a subsidiary of Bourne Capital Partners LLC, is a pharmaceutical services company which offers distribution, licensing and commercialization of health care products. The company offers clinical trial sourcing solutions, regulatory affairs management a …
  • United States Postal Service:企業の戦略・SWOT・財務分析
    United States Postal Service - Strategy, SWOT and Corporate Finance Report Summary United States Postal Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Q BioMed Inc (QBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Q BioMed Inc (Q BioMed), formerly ISMO Tech Solutions Inc, is a biomedical acceleration and development company. The company offers Strontium Chloride SR89, a radiopharmaceutical agent for the treatment of pain associated with metastatic bone cancer. It develops Man-01, a pre-clinical lead c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆